Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-16

FDA Approved: SUMATRIPTAN — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s Sumatriptan generic under an Original Application (ANDA200183).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)